Search Results
Mar 04, 2026, 17:00 ET Nanalysis Announces Grant of Options and Restricted Share Units
Nanalysis Scientific Corp. (TSXV: NSCI, FRA: 1N1) Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company
More news about: Nanalysis Scientific Corp.
Feb 17, 2026, 09:00 ET Devonian Advances Thykamine™ Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls
HPLC-MS methodology has demonstrated high reproducibility across manufactured batches of Thykamine™, a result independently confirmed by NMR (Nuclear Magnetic Resonance) analysis, showing ≥98% confidence in batch-to-batch consistency.Batch reproducibility was further validated through
More news about: Devonian Health Group Inc.
Feb 12, 2026, 17:00 ET AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE
lands), the Crown holds the subsurface mineral rights and imposes a net profits royalty (the "Crown royalty") under the Nunavut Mining Regulations (the "NMR"). The Company does not include the Crown royalty in its calculations of total cash costs per ounce and certain other of its non-GAAP measures as the
More news about: Agnico Eagle Mines Limited
Feb 09, 2026, 03:01 ET Improved Pharma Announces Enhanced X-Ray Diffraction and Interpretation Services to Strengthen Market Authorization Applications and Patents
distinguish amorphous character from poorly crystalline statesOrthogonal integration: corroboration of PXRD data with Raman mapping, solid-state NMR, and thermal analysisRegulatory & intellectual property support: Data packages specifically designed for chemistry, manufacturing and controls
More news about: Improved Pharma
Jan 27, 2026, 10:01 ET Proteomics Market worth $65.78 Billion by 2030 | MarketsandMarkets™
biological interpretation through robust protein identification and quantification methods. The spectroscopy sub-market is segmented into mass spectroscopy, NMR spectroscopy, and CD spectroscopy.Request Sample Pages@
More news about: MarketsandMarkets
Jan 26, 2026, 16:15 ET Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering
Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company
More news about: Nanalysis Scientific Corp.
Jan 05, 2026, 08:05 ET SynuSight Biotech, ABLi Therapeutics and XingImaging Announce Strategic Collaboration to Implement Alpha-Synuclein PET Imaging into Clinical Trials Evaluating Risvodetinib as a Disease-modifying Therapy for Parkinson's disease
alpha-synuclein, tau, and A-beta. By integrating cutting-edge technologies like Cryo-EM electron diffraction, helical filament imaging, and In-cell NMR spectroscopy, we have built unparalleled expertise in key neurodegenerative disease targets, unlocking new possibilities for innovative therapeutic solutions
More news about: SynuSight Biotech
Dec 23, 2025, 16:15 ET Nanalysis Announces Upsize to Private Placement and Closing of the First Tranche
Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company
More news about: Nanalysis Scientific Corp.
Dec 17, 2025, 03:30 ET numares Health enters ASEAN region with regulatory approval in Malaysia and first contract win for AXINON® LDLp Test System
multidimensional biomarker insights and clinical pathways for optimal patient care. Its highly automated digital conversion of biochemical pathways uses NMR spectra to simultaneously measure hundreds of biomarkers from a single, minimally-processed sample, ensuring precise, consistent, scalable and streamlined
More news about: numares Health
Dec 08, 2025, 08:00 ET Nanalysis Announces $2.5 Million Private Placement
Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company
More news about: Nanalysis Scientific Corp.
Nov 24, 2025, 16:52 ET Nanalysis Announces Third Quarter 2025 Results
supplier alternatives and strengthening its ability to meet customer demand and support growth in its benchtop NMR product lines.Announcement of the first regulated benchtop NMR assay for pharmaceutical quality control: acceptance of the Molar Substitution Determination in Hydroxypropyl
More news about: Nanalysis Scientific Corp.
Nov 18, 2025, 08:00 ET Nanalysis Announces Third Quarter 2025 Conference Call
Nanalysis Scientific Corp. ("the Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications announces that on Monday, November 24th, 2025, the Company will
More news about: Nanalysis Scientific Corp.
Nov 17, 2025, 05:26 ET Corporate Event Services in U.S Market to Reach $57.86 Billion, by 2035 at 6.3% CAGR: Allied Market Research
Nth Degree Globalmeet Eventzilla Gartner NMR events Opus Event Agency. The report analyzes these key players in the U.S.
More news about: Allied Market Research
Nov 14, 2025, 08:00 ET Nanalysis Announces Change of Management
NSCIF, FRA: 1N1) Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company
More news about: Nanalysis Scientific Corp.
Nov 11, 2025, 11:01 ET Molecular Spectroscopy Market to Reach $6.4 billion, Globally, by 2034 at 5% CAGR: Allied Market Research
In April 2024, Bruker Corporation, the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announced the introduction of novel high-resolution solid-state NMR scientific capabilities that can enable unprecedented structural biology discoveries in large proteins,
More news about: Allied Market Research
Oct 09, 2025, 05:10 ET Solvents Market to Reach $66 Million, Globally, by 2034 at 6% CAGR: Allied Market Research
globally are actively engaged in innovative studies requiring high-quality solvents for various applications, including nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and chromatography. The pursuit of new chemical entities and materials drives the need for solvents that offer consistency
More news about: Allied Market Research
Oct 08, 2025, 08:34 ET Scientific Equipment Goes to Auction in Tiger Group and EquipNet Sale on Oct. 16
many others. One coveted piece available in the sale, Spinelli noted, is a 2021 Bruker Ultrashield nuclear magnetic resonance (NMR) spectrometer (400MHz, 54mm), stored in Lansdale, Pennsylvania. "We can connect buyers with a firm that specializes in transporting these systems," Spinelli
More news about: Tiger Group
Oct 07, 2025, 17:00 ET Nanalysis announces support from Wiley for NMR Instruments in KnowItAll 2026
direct access to Wiley's comprehensive NMR data collections* for streamlined compound identification. Wiley's KnowItAll NMR database collection currently contains over 1.28 million 1D spectra for 1H-NMR, 13C-NMR, and X-NMR (11B, 15N, 17O,
More news about: Nanalysis Scientific Corp.